SUNNYVALE, Calif., Feb. 14, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the completion of the annual CyberKnife Scientific Meeting held February 10-12, 2011, in San Francisco, Calif. The global event hosted over 340 users of the CyberKnife® Robotic Radiosurgery System representing 12 countries. The three-day meeting brought together surgeons, radiation oncologists, therapists, medical physicists and other associated professionals to share the latest scientific data and exchange information about the use of the CyberKnife System to treat a broad range of malignant and benign tumors.
"It has been a pivotal year for the CyberKnife System, with new and exciting research published and presented in the fields of lung, prostate and breast cancer, and continued significant growth in clinical adoption worldwide across all clinical indications," said Omar Dawood, vice president of global medical affairs at Accuray. "We are proud to sponsor annual scientific meetings for CyberKnife users, such as this year's CyberKnife Summit, to facilitate the exchange of clinical and technical experiences with the common goal of furthering the field of full body radiosurgery."
This year's meeting featured clinical and technical presentations on a broad range of CyberKnife indications including prostate, lung, liver, breast, spine and brain tumors. Many of these presentations focused on the long term outcomes following CyberKnife radiosurgery as well as quality of life benefits.
As in past years, this year's summit also featured a session focused on Performance Improvement case reviews and Patient Safety. This session was sponsored by the University of Pittsburgh Cancer Institute designed to create an open forum for discussion of treatment experiences to ensure patient safety and the highest level of ca